Long-Term Outcomes of Dose-Escalated Hypofractionated Radiotherapy in Localized Prostate Cancer

SIMPLE SUMMARY: Moderately hypofractionated radiotherapy (HFRT) has been shown to be isoeffective compared to conventional regimens in the treatment of prostate cancer (PCa). In addition, dose-escalation improves biochemical or metastasis control with minimal toxicity, although no overall survival b...

Descripción completa

Detalles Bibliográficos
Autores principales: Lazo, Antonio, de la Torre-Luque, Alejandro, Arregui, Gregorio, Rivas, Daniel, Serradilla, Ana, Gómez, Joaquin, Jurado, Francisca, Núñez, María Isabel, López, Escarlata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945092/
https://www.ncbi.nlm.nih.gov/pubmed/35336808
http://dx.doi.org/10.3390/biology11030435

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945092/
https://www.ncbi.nlm.nih.gov/pubmed/35336808
http://dx.doi.org/10.3390/biology11030435

Ejemplares similares